Patented technology "innovative" and with "industrial applicability"

Tel-Array filed an international patent application on the Spot Profiler biosensor and cartridge system in September 2017, which was reviewed by the Canadian Patent Office and subsequently published in April 2018.

The International Search Authority (ISA) concludes the technology to be “innovative” and with “industrial applicability”.

National patent applications to be filed in 2019 in select countries of interest.

Categories: Publication

Published on by Winnie So.

Meeting with Dr. Saul Isserow

Tel-Array co-founders and management had an insightful meeting with Scientific Advisory Board member, Dr. Saul Isserow to discuss the future of the company's technology and products.

Dr. Isserow is the Director of both Cardiovascular Health at Vancouver General Hospital (VGH) and Cardiology Services at University of British Columbia Hospital (UBC Hospital). He is a leading figure in the cardiology medical field and well-connected with other medical and laboratory specialists.

Tel-Array appreciates the time and support Dr. Isserow provides to the company, especially with respect to Tel-Array's cardiovascular disease test panel. Tel-Array looks forward to continuing the relationship with Dr. Isserow and reaching other members of the medical community.

Dr. Saul Isserow (middle) and Tel-Array co-founders Dr. Hong Zhang (left) and Dr. William Campbell (right)

Dr. Saul Isserow (middle) and Tel-Array co-founders Dr. Hong Zhang (left) and Dr. William Campbell (right)

Categories: Meeting

Published on by Winnie So.